125 related articles for article (PubMed ID: 38677539)
1. Inhibition of human UDP-glucuronosyltransferase enzyme by entrectinib: Implications for drug-drug interactions.
Yin H; Wang Z; Lv X; Wang Z; Wang Y; Fan W; Li S; Jiang L; Cao J; Liu Y
Chem Biol Interact; 2024 May; 395():111023. PubMed ID: 38677539
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human UDP-glucuronosyltransferase enzyme by ripretinib: Implications for drug-drug interactions.
Lv X; Wang Z; Wang Z; Yin H; Xia Y; Jiang L; Liu Y
Toxicol Appl Pharmacol; 2023 May; 466():116490. PubMed ID: 36963523
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human UDP-glucuronosyltransferase enzyme by Dabrafenib: Implications for drug-drug interactions.
Yin H; Wang Z; Wang X; Lv X; Fan X; Yan M; Jia Y; Jiang L; Cao J; Liu Y
Biomed Chromatogr; 2021 Nov; 35(11):e5205. PubMed ID: 34192355
[TBL] [Abstract][Full Text] [Related]
4. Drug-drug interaction potentials of tucatinib inhibition of human UDP-glucuronosyltransferases.
Lv X; Wang Z; Wang Z; Yin H; Xia Y; Jiang L; Liu Y
Chem Biol Interact; 2023 Aug; 381():110574. PubMed ID: 37263554
[TBL] [Abstract][Full Text] [Related]
5. Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast.
Oda S; Fujiwara R; Kutsuno Y; Fukami T; Itoh T; Yokoi T; Nakajima M
Drug Metab Dispos; 2015 Jun; 43(6):812-8. PubMed ID: 25834030
[TBL] [Abstract][Full Text] [Related]
6. Piceatannol exhibits potential food-drug interactions through the inhibition of human UDP-glucuronosyltransferase (UGT) in Vitro.
Jiang L; Wang Z; Wang X; Wang S; Wang Z; Liu Y
Toxicol In Vitro; 2020 Sep; 67():104890. PubMed ID: 32446839
[TBL] [Abstract][Full Text] [Related]
7. Cabozantinib Carries the Risk of Drug-Drug Interactions
Wang Z; Jiang L; Wang X; Yin H; Wang Z; Lv X; Liu Y
Curr Drug Metab; 2022; 23(11):912-919. PubMed ID: 36306450
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human UDP-glucuronosyltransferase enzyme by belinostat: Implications for drug-drug interactions.
Wang X; Wang Z; Wang Z; Chen X; Yin H; Jiang L; Cao J; Liu Y
Toxicol Lett; 2021 Mar; 338():51-57. PubMed ID: 33290829
[TBL] [Abstract][Full Text] [Related]
9. Drug-Drug Interaction Potentials of Tyrosine Kinase Inhibitors via Inhibition of UDP-Glucuronosyltransferases.
Zhang N; Liu Y; Jeong H
Sci Rep; 2015 Dec; 5():17778. PubMed ID: 26642944
[TBL] [Abstract][Full Text] [Related]
10. In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug-drug interactions.
Lee SJ; Park JB; Kim D; Bae SH; Chin YW; Oh E; Bae SK
Toxicol Lett; 2015 Jan; 232(2):458-65. PubMed ID: 25448279
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the drug-drug interactions potential of ibrutinib and acalabrutinib via inhibition of UDP-glucuronosyltransferase.
Wang X; Wang Z; Fan X; Yan M; Jiang L; Xia Y; Cao J; Liu Y
Toxicol Appl Pharmacol; 2021 Aug; 424():115595. PubMed ID: 34038714
[TBL] [Abstract][Full Text] [Related]
12. A broad-spectrum substrate for the human UDP-glucuronosyltransferases and its use for investigating glucuronidation inhibitors.
Zhou QH; Qin WW; Finel M; He QQ; Tu DZ; Wang CR; Ge GB
Int J Biol Macromol; 2021 Jun; 180():252-261. PubMed ID: 33741369
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Inhibition of Human UDP-Glucuronosyl-Transferase (UGT) Isoforms by Astaxanthin, β-Cryptoxanthin, Canthaxanthin, Lutein, and Zeaxanthin: Prediction of in Vivo Dietary Supplement-Drug Interactions.
Zheng YF; Min JS; Kim D; Park JB; Choi SW; Lee ES; Na K; Bae SK
Molecules; 2016 Aug; 21(8):. PubMed ID: 27529203
[TBL] [Abstract][Full Text] [Related]
14. Ciprofol is primarily glucuronidated by UGT1A9 and predicted not to cause drug-drug interactions with typical substrates of CYP1A2, CYP2B6, and CYP2C19.
Hou L; Zhao Y; Zhao S; Zhang X; Yao X; Yang J; Wang Z; Chan ECY; Liu S
Chem Biol Interact; 2024 Jan; 387():110811. PubMed ID: 37993078
[TBL] [Abstract][Full Text] [Related]
15. Chirality Influence of Zaltoprofen Towards UDP-Glucuronosyltransferases (UGTs) Inhibition Potential.
Jia L; Hu C; Wang H; Liu Y; Liu X; Zhang YY; Li W; Wang LX; Cao YF; Fang ZZ
Chirality; 2015 Jun; 27(6):359-63. PubMed ID: 25903196
[TBL] [Abstract][Full Text] [Related]
16. Phloretin exhibits potential food-drug interactions by inhibiting human UDP-glucuronosyltransferases in vitro.
Chen J; Zhang H; Hu X; Xu M; Su Y; Zhang C; Yue Y; Zhang X; Wang X; Cui W; Zhao Z; Li X
Toxicol In Vitro; 2022 Oct; 84():105447. PubMed ID: 35868516
[TBL] [Abstract][Full Text] [Related]
17. Pterostilbene supplements carry the risk of drug interaction via inhibition of UDP-glucuronosyltransferases (UGT) 1A9 enzymes.
Jiang L; Zhang Z; Xia Y; Wang Z; Wang X; Wang S; Wang Z; Liu Y
Toxicol Lett; 2020 Mar; 320():46-51. PubMed ID: 31812603
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of aflatoxins on UDP-glucuronosyltransferases (UGTs).
Du Z; Liu ZZ
Toxicol In Vitro; 2023 Aug; 90():105612. PubMed ID: 37164184
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the inhibition potential of parthenolide and micheliolide on various UDP-glucuronosyltransferase isoforms.
Gao WF; Li YX; Zhang WH; Tao R; Yin TT; Wang YJ; Liu LN; Fu ZW; Li SN; Liu NR; Zhang H; Liu G; Zhao LZ; Zhang XP; Zhang CZ
Xenobiotica; 2019 Oct; 49(10):1158-1163. PubMed ID: 30484368
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the inhibition potential of Licochalcone A against human UDP-glucuronosyltransferases.
Xin H; Qi XY; Wu JJ; Wang XX; Li Y; Hong JY; He W; Xu W; Ge GB; Yang L
Food Chem Toxicol; 2016 Apr; 90():112-22. PubMed ID: 26875642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
